Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-7684-02 Phase 1 Study in Healthy Japanese Male Subjects
jRCT2071220101Phase 1Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial comparing ONO-7684 with Placebo (2 arms). Primary endpoints: Safety and tolerability and Pharmacokinetics. Started Mar 2023; status: completed.
02
Drugs
ONO-7684
Beyond the preview
Go deeper on jRCT2071220101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071220101.